Granules India net profit rises 39% to ₹182 cr on higher revenue
Granules is well positioned in its transition towards complex generics and peptide CDMO. | Photo Credit: The Hindu Drugmaker Granules India reported 39% year-on-year (YoY) jump in consolidated net profit to ₹181.8 crore in September quarter. The profit came on a 20% YoY increase in revenue from operations to ₹1,559.9 crore. Sequentially, however, the growth…
Read More “Granules India net profit rises 39% to ₹182 cr on higher revenue” »